The Effect of Dicumarol, Diphacinone and Pivalyl Upon Blood Prothrombin Time of Chicks
O.W. Charles+3 more
openalex +1 more source
Discrepancy between Thromboelastography and Prothrombin Time [PDF]
Evan G. Pivalizza+2 more
openalex +1 more source
Diagnostics of Autoimmune Hepatitis Enabled by Non‐Invasive Clinical Proteomics
Mass‐spectrometry‐based proteomic analyses of paired liver‐plasma samples from patients with AIH enabled discovery of numerous proteins showing high diagnostic accuracy. Proteomics may constitute a novel non‐invasive diagnostic tool for AIH if validated in larger, age‐ and sex‐matched cohorts.
Anne‐Sofie Houlberg Jensen+20 more
wiley +1 more source
Clinical Interpretation of the One-Stage Prothrombin Time
Armand J. Quick
openalex +1 more source
Anti‐PF4 disorders: Pathogenesis, diagnosis and treatment
Anti‐platelet factor 4 (PF4) disorders include heparin‐induced thrombocytopenia (HIT) and vaccine‐induced immune thrombocytopenia and thrombosis (VITT)/VITT‐like disorders. The formation of immunoglobulin G (IgG)/PF4 immune complexes facilitates uncontrolled activation of platelets, neutrophils and monocytes via IgG‐mediated Fcγ receptor binding.
Megan V. Preece+3 more
wiley +1 more source
Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population. [PDF]
Zhang F+11 more
europepmc +1 more source
Rapid Single-Tube Genotyping of the Factor V Leiden and Prothrombin Mutations by Real-Time PCR Using Dual-Color Detection [PDF]
F. A. J. T. M. van den Bergh+2 more
openalex +1 more source
Schematic representation of generation of 8‐gene‐edited cloned pigs and their verification by pig to non‐human primate kidney xenotransplantation. ABSTRACT Gene‐edited (GE) pig‐to‐human xenotransplantation continues to make breakthroughs, but which kind of gene combination is suitable for organ‐specific transplantation remains unclear.
Jiaoxiang Wang+23 more
wiley +1 more source
Activated Partial Thromboplastin Time or Prothrombin Time Prolongation During Rivaroxaban Administration: Clinical Risk Factors and Outcomes Analysis. [PDF]
Yuan Y, Li X, Qiu F.
europepmc +1 more source
Measurement of Prothrombin Time in EDTA Plasma with Combined Thromboplastin Reagent [PDF]
Juha Horsti
openalex +1 more source